Coya Therapeutics, Inc. (COYA)
5.01
+0.12
(+2.45%)
USD |
NASDAQ |
Sep 21, 16:00
5.01
0.00 (0.00%)
After-Hours: 20:00
Coya Therapeutics Shareholders Equity (Quarterly) : 43.28M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 43.28M |
| March 31, 2026 | 48.97M |
| December 31, 2025 | 43.03M |
| September 30, 2025 | 27.28M |
| June 30, 2025 | 28.31M |
| March 31, 2025 | 33.37M |
| December 31, 2024 | 39.58M |
| September 30, 2024 | 32.01M |
| June 30, 2024 | 35.26M |
| March 31, 2024 | 32.54M |
| Date | Value |
|---|---|
| December 31, 2023 | 35.65M |
| September 30, 2023 | 10.09M |
| June 30, 2023 | 13.25M |
| March 31, 2023 | 16.15M |
| December 31, 2022 | -8.394M |
| September 30, 2022 | -5.357M |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | 3.644M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 465.53M |
| Oncolytics Biotech, Inc. | -6.167M |
| Sangamo Therapeutics, Inc. | -18.96M |
| Sarepta Therapeutics, Inc. | 1.528B |
| Anixa Biosciences, Inc. | 14.47M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 47.31M |
| Total Liabilities (Quarterly) | 4.032M |
| Current Ratio | 13.40 |